Clinical Features and Molecular Markers on Diffuse Midline Gliomas With H3K27M Mutations: A 43 Cases Retrospective Cohort Study

PURPOSE: Diffuse midline gliomas (DMG) with H3K27M mutations have been identified as a rare distinctive entity with unique genetic features, varied molecular alterations, and poor prognosis. The current study aimed to evaluate the clinical characteristics and profile of molecular markers on patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuan, Feng, Lan-lan, Ji, Pei-gang, Liu, Jing-hui, Guo, Shao-chun, Zhai, Yu-long, Sankey, Eric W., Wang, Yue, Xue, Yan-rong, Wang, Na, Lou, Miao, Xu, Meng, Chao, Min, Gao, Guo-Dong, Qu, Yan, Gong, Li, Wang, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917281/
https://www.ncbi.nlm.nih.gov/pubmed/33659209
http://dx.doi.org/10.3389/fonc.2020.602553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917281/
https://www.ncbi.nlm.nih.gov/pubmed/33659209
http://dx.doi.org/10.3389/fonc.2020.602553

Ejemplares similares